Would the money and time to produce this product be better spent on uplisting?
The issue is "major money" institutional investors cannot invest in an OTC exchange. The millions of people with 401k's will not be able to participate AND when they call their fund administrators, they will be told they cannot invest in this company because it is listed on the "Stinky Pinky Penny Exchange".